Overall, 2021 is promised to be the year of recovery – this is the consensus of the overwhelming majority of analysts. However, substantial uncertainty remains depending on how successful the vaccine distribution and acceptance will be.
Even though the struggle of production and distribution is yet to be overcome and the anti-pandemic restrictions in many countries are yet to be lifted, global stock markets finished their best month on record in November. In the US, almost a month after the elections, the political turmoil is closer to a resolution now that the incumbent president has agreed to start the transition process - even though at the same time he promised to continue challenging the results of the elections. It is somewhat apparent now that for the next two years the country will be governed by a democratic White House and a mostly republican Senate – the combination which markets also perceived as good news. Markets’ optimism, however, looks a little bit premature considering the recent macroeconomic data.
Tactical Asset Allocation
Liquidity |
Neutral |
Bonds |
Neutral |
Equities |
Neutral |
Alternative Investments |
Neutral |
Macroeconomics
After the spectacular crash in 2020, 2021 is expected to bring a strong recovery in the world. The output, however, will not get back to the pre-pandemic level at least until 2022 in most countries. Moreover, high unemployment levels pose a great challenge to the world.
Overall, the uncertainty remains substantial: the path of recovery largely depends on the pandemic-related developments.
Fixed Income
The markets traded in November in line with the global risk-on sentiment, which was driven by the election result and news of potential vaccines bringing an end to the pandemic.
Although US Treasury 10yr yields shoot up 15 bps to 0.97 on the vaccine news, the full conviction of an economic recovery was missing as the number of new COVID-19 cases increased day by day. It looks like that rates markets want to have the facts for an economic recovery on the table. Currently, they are just slowly adapting to the bullish equity scenario.
A Bloomberg survey shows economists’ forecasts for US 10y yields at 0.91 by the end Q1 2021.
Credit markets behaved differently, much closer to equities. US and European HY spreads tightened around 100 bps, its biggest move since April/May. Currently, markets are trading close to pre COVID-19 levels. Bonds from down beaten sectors like airlines and retail performed best.
Similar behaviour we saw in Emerging Markets but not to the same extend. We like the sector as it still has some potential to perform, especially with the current raise in oil-price.
With an expected vaccine roll out in 1H21, provided support from central banks and fiscal stimulus continues, we expect the hunt for yield to continue with higher beta names outperforming.
Fixed Income
For credit we remain rather positive although spreads narrowed significantly and trade close to their historic lows. The hunt for yield is going to continue with investors forced to go down the credit curve.
An expected economic recovery will favour higher beta names which still have some room to tighten. Auto, Oil, Cyclicals and Consumer Finance are the sectors which have the most potential. Another segment we overweight in our portfolios is hard currency Emerging Markets bonds.
Equities
The outlook for equity markets among investors and analysts can be described as cautiously optimistic. A new economic and interest rate cycle has begun, and the economy is in the early stages of recovery. This is signified by the positive response on the stock markets and a steepening yield curve.
Equity Indicators
Valuation |
Neutral |
Momentum |
Neutral |
Seasonality |
Attractive |
Macro-Economics |
Neutral |
In 2021 we expect a valuation adjustment along all asset classes. In case of equities, this should be achieved via improved corporate earnings prospects.
The economic tailwind should boost the sensitive sectors such as basic materials, industrial goods, and consumer discretionary, as well as the smaller and medium-sized tech companies. However, we expect large caps, especially mega-caps in the U.S., to take a breather in 2021 after years of outperformance.
Alternatives
Currencies that are positively dependent on the global economic cycle may benefit in 2021. This applies all to commodity and procyclical currencies. The EUR is also likely to appreciate further due to the trend towards USD weakness, albeit to a somewhat lesser extent than other cyclical currencies.
The future development of gold price is determined by three factors: the trend of the USD, real yields, and inflation expectations. In 2021, we expect it to retest its record high and even slightly exceed it.
In the wake of the economic recovery, commodity prices in general should also have additional upside potential in 2021.
Among hedge funds, we focus on strategies that benefit from vaccine announcements and related shifts in positioning.
Note: This report is published by Clarus Capital Group AG

Roger Ganz, Head Asset Management, Clarus Capital Group AG
Dejan Ristic, Partner, Clarus Capital Group AG
Disclaimer
This document has been prepared by Clarus Capital Group AG ("Clarus Capital"). This document and the information contained herein are provided solely for information and marketing purposes. It is not to be regarded as investment research, sales prospectus, an offer or a solicitation of an offer to enter in any investment activity or contractual relation. Please note that Clarus Capital retains the right to change the range of services, the products and the prices at any time without notice and that all information and opinions contained herein are subject to change.
This document is not a complete statement of the markets and developments referred to herein. Past performance and forecasts are not a reliable indicator of future performance. Investment decisions should always be taken in a portfolio context and make allowance for your personal situation and consequent risk appetite and risk tolerance. This document and the products and services described herein are generic in nature and do not consider specific investment objectives, financial situation or particular needs of any specific recipient. Investors should note that security values may fluctuate, and that each security’s price or value may rise or fall. Accordingly, investors may receive back less than originally invested. Individual client accounts may vary. Investing in any security involves certain risks called non-diversifiable risk. These risks may include market risk, interest-rate risk, inflation risk, and event risk. These risks are in addition to any specific, or diversifiable, risks associated with particular investment styles or strategies.
Clarus Capital does not provide legal or tax advice and makes no representations as to the tax treatment of assets or the investment returns thereon, either in general or with reference to specific client's circumstances and needs. Recipients should obtain independent legal and tax advice on the implications of the products and services in the respective jurisdiction before investing. Certain services and products are subject to legal provisions and cannot be offered world-wide on an unrestricted basis. In particular, this document is not intended for distribution in jurisdictions where its distribution by Clarus Capital would be restricted. Clarus Capital specifically prohibits the redistribution of this document in whole or in part without the written permission of Clarus Capital and Clarus Capital accepts no liability whatsoever for the actions of third parties in this respect. Neither Clarus Capital nor any of its partners, employees or finders accepts any liability for any loss or damage arising out of the use of all or any part of this document. Source of all information is Clarus Capital unless otherwise stated. Clarus Capital makes no representation or warranty relating to any information herein which is derived from independent sources. Please consult your client advisor if you have any questions.